US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

fentaNYL 100 mcg/2mL Injection for IV or IM Use

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0214-2021
Class II · Moderate risk Terminated

SUCcinylcholine Chloride 100 mg/5mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0212-2021
Class II · Moderate risk Terminated

Rocuronium Br 50 mg/5mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0211-2021
Class II · Moderate risk Terminated

SUCccinylcholine Chloride 200 mg/10 mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0208-2021
Class II · Moderate risk Terminated

Sodium Citrate 4% 3 mL Anticoagulation Solution

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0207-2021
Class II · Moderate risk Terminated

Rocuronium Br 100 mg/10mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0206-2021
Class II · Moderate risk Terminated

neostigmine methylsulfate 5 mg/5 mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0203-2021
Class II · Moderate risk Terminated

Lidocaine HCl 2% 5 mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0200-2021
Class II · Moderate risk Terminated

Lidocaine HCl 1% 10 mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0199-2021
Class II · Moderate risk Terminated

labetalol HCl 20 mg/4 mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0198-2021
Class II · Moderate risk Terminated

Glycopyrrolate 1 mg/5mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0194-2021
Class II · Moderate risk Terminated

fentaNYL 1500 mcg/30 mL

Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

SCA Pharmaceuticals D-0193-2021